SAN DIEGO, Aug. 28, 2012 /PRNewswire/ -- Accelrys, Inc.
(NASDAQ: ACCL), a leading provider of scientific innovation
lifecycle management software, has announced that the latest
release of the company's enterprise electronic laboratory notebook
(ELN), Symyx Notebook by Accelrys, offers a new multidimensional
scientific spreadsheet for use in planning, executing and tracking
a wide range of biological experiments. In addition, powerful new
project tracking and optimization software provides a more complete
biology solution, from efficient study orchestration to study
execution in the lab. Together, the new ELN capabilities accelerate
scientific innovation lifecycle management across a range of
chemical and biological experimentation, helping bridge the
productivity gap from innovation through commercialization.
To view the multimedia assets associated with this release,
please click
http://www.prnewswire.com/news-releases/accelrys-eln-advances-innovation-lifecycle-management-with-enhanced-biology-capabilities-from-screening-to-preclinical-development-167625565.html
By significantly improving bench scientists' ability to capture,
mine and reuse experiment and study information from within the
ELN, the new scientific spreadsheet improves data access, enhances
knowledge management and reduces laboratory cycle times. The new
project tracking and optimization capabilities improve
collaboration and cascade management for project teams while
enhancing study visibility and capacity management for study
directors.
"The new spreadsheet and unique project tracking capabilities
accelerate end-to-end innovation productivity for discovery and
development scientists, especially those working in preclinical
development," said Accelrys' Senior Vice President and Chief
Technology Officer, Dr. Matt Hahn.
"We have seen significant cycle time reductions resulting from
improved information flow across the research cascade and more
streamlined coordination of tasks and teams in this collaborative
environment."
Integration of the new notebook capabilities with the
scientifically aware Accelrys Enterprise Platform supports the
combined management of information, tasks and collaboration from
early-phase screening and assay development through downstream drug
metabolism and pharmacokinetics, ADMET, bioanalytical and in
vivo pharmacology. The Platform's extensive scientific
Component Collections, built on Accelrys' deep domain expertise in
chemistry, biology, materials science, informatics and predictive
science, rapidly and cost-effectively deliver advanced imaging,
modeling and analytics capabilities supporting scientific workflows
from research to development.
Today's drug discovery process requires coordination among
multiple teams within the enterprise and, increasingly, across
geographical and organizational boundaries. In this challenging
R&D environment, the new ELN capabilities from Accelrys improve
access to information, foster better collaboration and speed
laboratory cycle times by providing:
- A multidimensional scientific spreadsheet with flexible
templates that enable teams to capture, analyze, report and share
data from plate-based screening experiments to behavioral
studies
- Enhanced data management, storage and access, enabling
rapid data aggregation, searching and reporting for improved
insights and faster decisions
- An integrated system for tracking and optimizing project,
study and laboratory workflows. The system supports cascades of
services with progression rules for transitioning activities from
one stage to the next. Interactive reports record materials and
resource usage across the cascades, highlighting bottlenecks and
empowering managers to fine-tune resource utilization and
allocation
For more information on informatics-driven study orchestration
and execution in preclinical development, visit
accelrys.com/micro/notebook/preclinical.html. You can also register
for the complimentary webinar, "Informatics-Driven Project
Execution for In Vivo Pharmacology," scheduled for
8 a.m. PDT, Wednesday, Sept. 12.
About Accelrys, Inc.
Accelrys (NASDAQ:ACCL), a leading provider of scientific
innovation lifecycle management software, supports industries and
organizations that rely on scientific innovation to differentiate
themselves. The industry-leading Accelrys Enterprise Platform
provides a broad, flexible scientific solution optimized to
integrate the diversity of science, experimental processes and
information requirements across the research, development, process
scale-up and early manufacturing phases of product development. By
incorporating capabilities in applications for modeling and
simulation, enterprise lab management, workflow and automation, and
data management and informatics, Accelrys enables scientific
innovators to access, organize, analyze and share data in
unprecedented ways, ultimately enhancing innovation, improving
productivity and compliance, reducing costs and speeding time from
lab to market.
Accelrys solutions are used by more than 1,300 customers in the
pharmaceutical, biotechnology, energy, chemicals, aerospace,
consumer packaged goods and industrial products industries.
Headquartered in San Diego,
Calif., Accelrys employs more than 200 full-time PhD
scientists. For more information about Accelrys, visit
www.accelrys.com.
Related Links:
Pre-clinical ELN Solutions
Accelrys Website
SOURCE Accelrys, Inc.